Extended hepatic metastasectomy for renal cell carcinoma—new aspects in times of targeted therapy: a single-center experience over three decades

Purpose Despite the introduction of novel targeted therapies on patients with renal cell carcinoma, syn- and metachronous metastases (including hepatic lesions) are observed frequently and significantly influence patient survival. With introduction of targeted therapies as an effective alternative t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Langenbeck's archives of surgery 2020-02, Vol.405 (1), p.97-106
Hauptverfasser:	Beetz, Oliver, Söffker, Rabea, Cammann, Sebastian, Oldhafer, Felix, Vondran, Florian W. R., Imkamp, Florian, Klempnauer, Jürgen, Kleine, Moritz
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Surgery Adult Aged Aged, 80 and over Antineoplastic Agents - administration & dosage Carcinoma, Renal Cell - drug therapy Carcinoma, Renal Cell - secondary Carcinoma, Renal Cell - surgery Cardiac Surgery Female General Surgery Hepatectomy - methods Hepatectomy - mortality Humans Kaplan-Meier Estimate Kidney Neoplasms - drug therapy Kidney Neoplasms - pathology Kidney Neoplasms - surgery Liver Neoplasms - drug therapy Liver Neoplasms - secondary Liver Neoplasms - surgery Male Medicine Medicine & Public Health Metastasectomy - methods Metastasectomy - mortality Middle Aged Models, Theoretical Molecular Targeted Therapy Nephrectomy Original Original Article Prognosis Retrospective Studies Risk Assessment Sunitinib - therapeutic use Thoracic Surgery Traumatic Surgery Vascular Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!